Research Article
Identification of Missense Mutation (I12T) in the BSND Gene and Bioinformatics Analysis
Table 1
Clinical and biochemical features of normal and affected members of studied family.
| Features | Reference ranges | Normal members |
Affected members from the family with hearing loss | V : 3 | V : 5 | V : 1 | VI : 3 | VI : 5 |
| Age (y) | | 30 | 35 | 45 | 12 | 10 | Other symptoms of BSIV | | no | no | No | No | No | Na (mmol/L) | 136–148 | 141 | 140 | 135 | 137 | 134 | SK (mmol/L) | 3.6–5.0 | 3.9 | 4.6 | 3.4 | 3.5 | 3.5 | SCl (mmol/L) | 104–114 | 105 | 107 | 97 | 102 | 101 | SMg (mg/dl) | 1.9–2.5 | 2.3 | 2.2 | 2.0 | 1.9 | 2.1 | SHCO3 (mmol/L) | 17.5–27.5 | 30.0 | 27.5 | 30.0 | 30.2 | 31.0 | SCa (mg/dl) | 8.6–10.5 | 8.7 | 9.5 | 9.2 | 9.8 | 10.0 | SCreatinine (mg/dL) | 0.85–1.35 | 0.7 | 0.8 | 0.6 | 0.5 | 0.4 | Renin (ng/ml/hr) | 0.15–2.33 | 0.31 | 0.6 | 2.13 | 2.03 | 2.53 | SAldosterone (ng/dL) | 1–6; 4–31 | >1.7f | 13.0 | 10.3 | 11.9 | 6.3 | SOsmolality (mosm/kg) | 275–295 | 293 | 289 | 281 | 290 | 287 | Na (mmol/L) | 30–150 | 17.5 | 154.6 | 39.1 | 16.9 | 13.3 | UK (mmol/L) | 20–67 | 3.4 | 91.31 | 12.13 | 8.43 | 4.12 | UCa (mg/dL) | | 6.0 | 16.0 | 15.3 | 11.3 | 13.0 | UMg (mg/dL) | | 3.6 | 14.4 | 3.1 | 2.4 | 1.12 | UCl (mmol/L) | 46–168 | 16.3 | 174.3 | 46.56 | 19.2 | 10.5 | Uosmolality (mosm/kg) | 50–1400 | 74 | 903 | 179 | 105 | 56 | NephrocacinosisS | | Absent | Absent | Absent | Absent | Absent |
|
|